Research peptide
BPC-157
Human evidence is sparse and inadequate to establish efficacy, dosing, or long-term safety.
Why it is discussed
Injury-recovery and gastrointestinal claims
BPC-157 is commonly discussed for tendon, ligament, wound, and gastrointestinal recovery. Most supportive claims are extrapolated from laboratory or animal work; reliable human evidence is too limited to establish effectiveness, dosing, or long-term safety.
What it is
An experimental 15-amino-acid peptide.
BPC-157 is a synthetic peptide investigated in tissue-injury and repair models. It is often discussed as though it has a single proven healing action, but the cited work examines several cellular pathways. A complete therapeutic mechanism in humans has not been established.
How it works
Proposed repair pathways—not a proven human healing mechanism.
In cultured rat tendon fibroblasts, researchers reported increased expression of the growth-hormone receptor and altered responses to growth hormone. Receptor expression means how much of that cellular target is produced; it does not mean BPC-157 is growth hormone or repairs a human tendon.
Other cell and animal experiments investigated VEGFR2, a receptor involved in blood-vessel signaling. Reported effects on this pathway and vessel formation help explain scientific interest in tissue repair. They are not clinical proof that promoting these processes is beneficial or safe in a particular injury.
The proposed pathways should therefore be read as preclinical findings. They do not establish a reliable human benefit, route of administration, or equivalence between research preparations and products sold online.
Scientific / evidence sources
Evidence at a glance
What is established—and what is not.
Primarily preclinical evidence with sparse human data
Laboratory and animal research has generated hypotheses involving tissue and gastrointestinal biology.
Reliable human efficacy, a safe human regimen, long-term safety, and the clinical relevance of many marketed claims remain unestablished.
Regulatory status
Canada and the United States are checked separately.
No authorized human drug identified in the current source review.
No FDA-approved product; FDA describes limited safety information and characterization concerns.
Regulatory status describes product authorization and relevant regulatory context. It is not a complete legal opinion about possession, importation, prescribing, sale, or professional practice.
If you are reviewing a product report
The molecule profile and the testing report answer different questions.
This page summarizes evidence and regulatory context. A laboratory report may address identity, purity, or quantity for one submitted sample; it does not transfer clinical evidence or product authorization.